We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+47.61%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$664M
AUM Growth
+$53.7M
Cap. Flow
-$65.4M
Cap. Flow %
-9.85%
Top 10 Hldgs %
8.56%
Holding
488
New
196
Increased
26
Reduced
99
Closed
166

Top Sells

Rank Stock Value
1
APAM icon
Artisan Partners
APAM
+$7.7M
2
GNTX icon
Gentex
GNTX
+$7.08M
3
OCUL icon
Ocular Therapeutix
OCUL
+$6.06M
4
CELH icon
Celsius Holdings
CELH
+$5.29M
5
GRWG icon
GrowGeneration
GRWG
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Consumer Discretionary 19.32%
3 Industrials 18.98%
4 Healthcare 16.09%
5 Financials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
326
Agilysys
AGYS
$3.06B
-56,313
Closed -$2.16M
AHCO icon
327
AdaptHealth
AHCO
$759M
-50,091
Closed -$1.88M
ALK icon
328
Alaska Air
ALK
$5.58B
-31,443
Closed -$1.64M
ALLK
329
DELISTED
Allakos
ALLK
-14,191
Closed -$1.99M
ALRM icon
330
Alarm.com
ALRM
$2.85B
-28,838
Closed -$2.98M
ALXO icon
331
ALX Oncology
ALXO
$290M
-19,645
Closed -$1.69M
AMRC icon
332
Ameresco
AMRC
$1.36B
-59,488
Closed -$3.11M
AMSC icon
333
American Superconductor
AMSC
$1.59B
-76,895
Closed -$1.8M
APAM icon
334
Artisan Partners
APAM
$3.02B
-152,934
Closed -$7.7M
APLS
335
DELISTED
Apellis Pharmaceuticals
APLS
-36,677
Closed -$2.1M
APPN icon
336
Appian
APPN
$2.48B
-14,280
Closed -$2.31M
ARVN icon
337
Arvinas
ARVN
$572M
-26,534
Closed -$2.25M
ARWR icon
338
Arrowhead Research
ARWR
$12.4B
-31,690
Closed -$2.43M
ATRA icon
339
Atara Biotherapeutics
ATRA
$76.1M
-1,987
Closed -$975K
ATRO icon
340
Astronics
ATRO
$3.84B
-96,677
Closed -$1.07M
BE icon
341
Bloom Energy
BE
$64.6B
-74,149
Closed -$2.13M
BEAM icon
342
Beam Therapeutics
BEAM
$2.84B
-23,642
Closed -$1.93M
BEEM icon
343
Beam Global
BEEM
$25.3M
-14,248
Closed -$1.05M
BGFV
344
DELISTED
Big 5 Sporting Goods
BGFV
-100,461
Closed -$1.03M
BL icon
345
BlackLine
BL
$1.72B
-21,288
Closed -$2.84M
BLFS icon
346
BioLife Solutions
BLFS
$1.7B
-47,636
Closed -$1.9M
BPMC
347
DELISTED
Blueprint Medicines
BPMC
-19,813
Closed -$2.22M
BWEN icon
348
Broadwind
BWEN
$109M
-160,186
Closed -$1.27M
BXC icon
349
BlueLinx
BXC
$706M
-33,460
Closed -$979K
CDLX icon
350
Cardlytics
CDLX
$21.5M
-1,548
Closed -$2.21M

Similar funds

EAM Investors's Q1 2021 Portfolio in Review

As of Q1 2021, EAM Investors held 488 positions worth $664M, up 8.8% from $611M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

EAM Investors withdrew a net $65.4M in Q1 2021, closing 166 positions and reducing 99 holdings. Its most notable exit was Artisan Partners, an estimated $7.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, EAM Investors opened a new position in Atkore worth $5.77M.

  • EAM Investors's largest Q1 2021 buy was Atkore: 80,194 shares worth $5.77M.
  • EAM Investors added most to The Shyft Group in Q1 2021, an estimated $2.05M increase.
  • EAM Investors's biggest Q1 2021 reduction was OptimizeRx, cutting an estimated $4.43M.
  • EAM Investors fully exited Artisan Partners in Q1 2021, selling an estimated $7.7M.
  • EAM Investors's ten largest holdings make up 8.6% of its $664M portfolio in Q1 2021.
  • EAM Investors opened 196 new positions and closed 166 in Q1 2021.
  • EAM Investors's portfolio value rose 8.8% quarter-over-quarter to $664M.

Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.